Prudential Financial Inc. lessened its holdings in shares of Clorox Co (NYSE:CLX) by 2.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 156,001 shares of the company’s stock after selling 3,930 shares during the quarter. Prudential Financial Inc.’s holdings in Clorox were worth $23,464,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Berkshire Asset Management LLC PA increased its position in shares of Clorox by 17.6% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 3,119 shares of the company’s stock valued at $469,000 after purchasing an additional 467 shares during the last quarter. Carillon Tower Advisers Inc. increased its position in shares of Clorox by 82.8% during the 2nd quarter. Carillon Tower Advisers Inc. now owns 109,150 shares of the company’s stock valued at $14,763,000 after purchasing an additional 49,450 shares during the last quarter. Legacy Advisors LLC bought a new position in shares of Clorox during the 3rd quarter valued at approximately $150,000. Victory Capital Management Inc. increased its position in shares of Clorox by 0.4% during the 2nd quarter. Victory Capital Management Inc. now owns 105,329 shares of the company’s stock valued at $14,246,000 after purchasing an additional 456 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. boosted its holdings in Clorox by 7.2% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 63,730 shares of the company’s stock valued at $8,620,000 after acquiring an additional 4,281 shares during the period. 76.33% of the stock is currently owned by institutional investors.
A number of equities analysts recently issued reports on CLX shares. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a report on Wednesday, October 3rd. Wells Fargo & Co boosted their price objective on Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 17th. Deutsche Bank cut Clorox from a “hold” rating to a “sell” rating and set a $123.00 price objective for the company. in a report on Wednesday, October 10th. Argus upgraded Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective for the company in a report on Tuesday, September 25th. Finally, Citigroup boosted their price objective on Clorox from $149.00 to $153.00 and gave the company a “neutral” rating in a report on Friday, November 2nd. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $142.79.
Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The business had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the business earned $1.46 EPS. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year. As a group, equities analysts forecast that Clorox Co will post 6.31 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be issued a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.36%. The ex-dividend date of this dividend is Tuesday, January 22nd. Clorox’s dividend payout ratio is 61.34%.
In other Clorox news, EVP Linda J. Rendle sold 382 shares of the company’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $148.32, for a total value of $56,658.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Jon M. Balousek sold 3,354 shares of the company’s stock in a transaction on Wednesday, August 29th. The stock was sold at an average price of $144.73, for a total value of $485,424.42. The disclosure for this sale can be found here. Insiders sold a total of 107,455 shares of company stock valued at $16,738,803 over the last quarter. Company insiders own 1.40% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Swap
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.